Use of nanocarriers for transdermal vaccine delivery

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 6, 2007, Pages 641-643

  Lawson, L B ^a   Freytag, L C ^a   Clements, J D ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; IMMUNOSUPPRESSIVE AGENT; NANOCARRIER; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; AGING; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; BIOLOGICAL WARFARE; CELL POPULATION; CELLULAR IMMUNITY; DENDRITIC CELL; DESMOSOME; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ECONOMIC ASPECT; ELECTROPORATION; FEASIBILITY STUDY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; HUMORAL IMMUNITY; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; INFLUENZA VIRUS; LYME DISEASE; MACROMOLECULE; MALARIA; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RISK ASSESSMENT; SHORT SURVEY; SKIN CELL; SKIN PERMEABILITY; SKIN STRUCTURE; STRATUM CORNEUM; TISSUE TRANSPLANTATION; TUBERCULOSIS; ULTRASOUND; VIRUS INFECTION;

ADMINISTRATION, CUTANEOUS; ANIMALS; HUMANS; MACROMOLECULAR SUBSTANCES; NANOCAPSULES; NANOTECHNOLOGY; SKIN ABSORPTION; VACCINES;

EID: 36148948249     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100425     Document Type: Short Survey

References (15)

1. Kripke, M.L., Munn, C.G., Jeevan, A., Tang, J.M. & Bucana, C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145, 2833-2838 (1990).
2. Glenn, G.M., Kenney, R.T., Hammond, S.A. & Ellingsworth, L.R. Transcutaneous immunization and immunostimulant strategies. Immunol. Allergy Clin. North Am. 23, 787-813 (2003).
3. Hauser, C., Elbe, A. & Stingl, G. The Langerhans cell. In Physiology, Biochemistry, and Molecular Biology of the Skin Vol. 2 (ed. Goldsmith, L.A.) 1144-1163 (Oxford University Press, New York, 1991).
4. Partidos, C.D., Beignon, A.S., Mawas, F., Belliard, G., Briand, J.P. & Muller, S. Immunity under the skin: potential application for topical delivery of vaccines. Vaccine 21, 776-780 (2003).
5. Nestle, F.O., Filgueira, L., Nickoloff, N.O. & Burg, G. Human dermal dendritic cells process and present soluble protein antigens. J. Invest. Dermatol. 110, 762-766 (1998).
6. Glenn, G.M., Taylor, D.N., Li, X., Frankel, S., Montemarano, A. & Alving, C.R. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. 6, 1403-1406 (2000).
7. Mitragotri, S. Breaking the skin barrier. Adv. Drug Deliv. Rev. 56, 555-556 (2004).
8. Babiuk, S., Baca-Estrada, M., Babiuk, L.A., Ewen, C. & Foldvari, M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J. Control. Release 66, 199-214 (2000).
9. Cevc, G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56, 675-711 (2004).
10. Wertz, P.W. & Downing, D.T. Epidermal lipids. In Physiology, Biochemistry, and Molecular Biology of the Skin Vol. 1 (ed. Goldsmith, L.A.) 205-236 (Oxford University Press, New York, 1991).
11. Cevc, G., Schatzlein, A.G., Richardson, H. & Vierl, U. Overcoming semipermeable barriers, such as the skin, with ultradeformable mixed lipid vesicles, transfersomes, liposomes, or mixed lipid micelles. Langmuir 19, 10753-10763 (2003).
12. Kohli, A.K. & Alpar, H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int. J. Pharm. 275, 13-17 (2004).
13. Copland, M.J. et al. Liposomal delivery of antigen to human dendritic cells. Vaccine 21, 883-890 (2003).
14. Morefield, G.L., Sokolovska, A., Jiang, D., HogenEsch, H., Robinson, J.P. & Hem, S.L. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23, 1588-1595 (2005).
15. Sun, H., Pollock, K.G.J. & Brewer, J.M. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21, 849-855 (2003).